Density Assessment
Reveal cancer’s hiding place.
Providing an objective and consistent breast density assessment, seamlessly integrated into existing workflows. ProFound is supporting personalized care plans and helping clinics align to new FDA-MQSA notification requirements.
FDA Cleared. CE Marked. Health Canada Licensed.
PowerLook® Density Assessment
Our Density Assessment solution simplifies and standardizes breast density reporting and stratification, with accurate and reliable results.
Using mammographic images, it analyzes the woman’s breast anatomy, and categorizes her breast density within the appropriate BI-RADS® 5th edition density category.
The result? Clinicians have an integrated workflow for identifying and reporting breast density, allowing them to personalize a patient’s care plan with supplemental screenings and a custom schedule.
Why density matters.
Breast density is one of the strongest and most prevalent breast cancer risk factors. As breast density increases, the risk of developing and missing breast cancer increases.
Align with industry guidelines and treatment standards.
ProFound Density supports standard clinician workflows and treatment standards.
Remove the challenges of subjectivity.
Standardizing density assessments can save lives.
Assessing breast density has traditionally been determined by the radiologist’s visual assessment, but studies show a 6-85% variation in subjective assessments, and that clinicians may even disagree with their own assessment year to year.7
Inconsistency can lead to unnecessary additional imaging, increase patient and facility costs, and cause anxiety and confusion for patients.
ProFound Density removes the challenges of subjectivity in breast density reporting.
Using 2D or 3D mammography images,, it analyzes and measures the adipose and fibroglandular tissue dispersion and texture of breast tissue, delivering clinicians a consistent, accurate, and reliable patient-specific breast density assessment.
Which breast should be identified as dense, requiring FDA-compliance patient notifications and a personalized, interval screening plan?
Clinicians are removing the subjectivity of that answer with ProFound Density.
What to look for in a Density Assessment solution.
Stay informed about breast density.
The Risk is Real. The Help is Here.
Explore our For Patients area to learn more about how breast density and other breast cancer risk factors are influencing the breast imaging experience for clinicians and patients.
Flexible turnkey solutions and service options designed to meet your unique deployment needs
ProFound Cloud
Connect via your private cloud, AI-marketplace, or directly with iCAD’s native cloud and Success Program.
ProFound On-Premises
Onsite hardware conveniently pre-loaded with iCAD software and tailored Success Program.
Interoperability: 50+ PACS & 94 versions | 2D & 3D OEM manufacturers | AI platform providers & workflow systems
Expert Voices
Joining forces against a common enemy.
In the fight against cancer, we’re stronger together. Learn why our customers believe that our solutions are the secret weapon for cancer detection and treatment.
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?
References
7. Sprague BL, Conant EF, Onega T, Garcia MP, Beaber EF, Herschorn SD, Lehman CD, Tosteson AN, Lacson R, Schnall MD, Kontos D, Haas JS, Weaver DL, Barlow WE; PROSPR Consortium. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med. 2016 Oct 4;165(7):457-464. doi: 10.7326/M15-2934. Epub 2016 Jul 19. PMID: 27428568; PMCID: PMC5050130.
iCAD data on file. Standalone performance varies by vendor.